NHS National Framework for Transition products commencing 1 May 2024
key details
| Value | £179,392,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 18 Mar 2024 |
| Procedure | open |
| OCID | ocds-h6vhtk-043aa8 |
Awards (24)
This procurement was awarded to 12 suppliers. Values shown are per-award; the notice total is £179,392,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Aspire Pharma Limited shared | £7,559,000 | 15 Apr 2024 | active |
| Aspire Pharma Limited shared | · | · | active |
| Celix Pharma Ltd. shared | £7,559,000 | 15 Apr 2024 | active |
| Celix Pharma Ltd. shared | · | · | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £7,559,000 | 15 Apr 2024 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | · | · | active |
| Glenmark Pharmaceuticals Europe Limited shared | £7,559,000 | 15 Apr 2024 | active |
| Glenmark Pharmaceuticals Europe Limited shared | · | · | active |
| Immedica Pharma AB shared | £7,559,000 | 15 Apr 2024 | active |
| Immedica Pharma AB shared | · | · | active |
| Kent Pharma Ltd shared | £7,559,000 | 15 Apr 2024 | active |
| Kent Pharma Ltd shared | · | · | active |
| LogixX Pharma Ltd shared | £7,559,000 | 15 Apr 2024 | active |
| LogixX Pharma Ltd shared | · | · | active |
| Mylan shared | £7,559,000 | 15 Apr 2024 | active |
| Mylan shared | · | · | active |
| Sandoz Ltd shared | £7,559,000 | 15 Apr 2024 | active |
| Sandoz Ltd shared | · | · | active |
| Selective Supplies Ltd. shared | £7,559,000 | 15 Apr 2024 | active |
| Selective Supplies Ltd. shared | · | · | active |
| Teva UK Limited shared | £7,559,000 | 15 Apr 2024 | active |
| Teva UK Limited shared | · | · | active |
| Thornton and Ross Ltd shared | £7,559,000 | 15 Apr 2024 | active |
| Thornton and Ross Ltd shared | · | · | active |
description
Project title: NHS National Framework for Transition products commencing 1 May 2024<br/>Offer reference number: CM/TNS/05/2024<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/05/2024/01<br/>Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)<br/>Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)<br/><br/>CM/TNS/05/2024/02<br/>Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
documents
- https://www.contractsfinder.service.gov.uk/Notice/5f33fdd2-03b0-44f8-a664-945d0d3b5b9a , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/00976dd6-3b77-419f-a130-aa4be0dad7c3
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/048c887b-c33a-4adb-86b6-7dd3a94ca01d
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/21b0037a-d9bd-4ed7-bfad-24b1aaeb3773
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2800c21a-b785-4d68-ae05-b8c857883eed
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/3259f66b-3bde-4621-a802-1d9300cc64b1
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/3f51c7c4-52b7-4814-a310-c9d7a7159fe1
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/42a1c05d-3458-475e-a8a6-6b993915df04
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/7d7421dd-3e0c-4f64-bc89-a09549d99be1
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/8212d3b1-e4f1-4336-a8da-d3e1bf68da47
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/8e9350a2-8305-4ff3-af3a-78e18bd27d9b
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/927369a8-f7d2-403e-8373-93db65e1208e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/a22c9d5e-6998-4e81-9921-4a867fc945fe
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ad611cf2-efca-4bc0-85e4-7ae7a50b8d84
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d6c0e86f-af09-4f67-8b4c-2d343aa22092
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/eb4322b1-fa3e-455b-a7b8-11eb66e294d9
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/f206727f-d8b2-4a12-8c8c-c482415ee2e0
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 16 Feb 2024 | Contract notice (F02) | Earlier regulations | 005193-2024 |
| 16 Feb 2024 | Tender (tender) | · | 5f33fdd2-03b0-44f8-a664-945d0d3b5b9a-724083 |
| 24 Apr 2024 | Contract award notice (F03) | Earlier regulations | 013260-2024 |
| 24 Apr 2024 | Award (award) | · | 414715d8-13f0-43f1-b262-2414d1189130-743806 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.